CTSO (STOCKS)
Cytosorbents Corp.
$0.585100
-0.024900 (-4.08%)
Prev close: $0.610000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Phillip P. Chan
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $37.94M
- Employees
- 149
- P/E (TTM)
- -4.39
- P/B (TTM)
- 6.49
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.09 | $-0.05 | -0.0390 | -76.47% |
|
Sep 2025 (Q3)
|
$-0.05 | $-0.05 | -0.0024 | -5.04% |
|
Jun 2025 (Q2)
|
$0.03 | $-0.05 | +0.0810 | +158.82% |
|
Mar 2025 (Q1)
|
$-0.02 | $-0.07 | +0.0514 | +71.99% |
Financial Statements
| Revenues | $37.06M |
| Benefits Costs and Expenses | $45.66M |
| Cost Of Revenue | $10.57M |
| Costs And Expenses | $45.66M |
| Gross Profit | $26.49M |
| Nonoperating Income/Loss | $6.15M |
| Operating Expenses | $41.24M |
| Selling, General, and Administrative Expenses | $35.65M |
| Depreciation and Amortization | $1.23M |
| Other Operating Expenses | $4.36M |
| Operating Income/Loss | -$14.75M |
| Income/Loss From Continuing Operations After Tax | -$8.20M |
| Income/Loss From Continuing Operations Before Tax | -$8.60M |
| Income Tax Expense/Benefit | -$401.00K |
| Income Tax Expense/Benefit, Current | -$401.00K |
| Net Income/Loss | -$8.20M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$8.20M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.20M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.13 |
| Diluted Earnings Per Share | -$0.13 |
| Basic Average Shares | 62,231,771 |
| Diluted Average Shares | 62,231,771 |
| Assets | $44.18M |
| Current Assets | $20.63M |
| Inventory | $5.28M |
| Other Current Assets | $15.35M |
| Noncurrent Assets | $23.55M |
| Fixed Assets | $7.82M |
| Other Non-current Assets | $15.73M |
| Liabilities | $38.28M |
| Current Liabilities | $9.71M |
| Accounts Payable | $2.87M |
| Other Current Liabilities | $6.84M |
| Noncurrent Liabilities | $28.57M |
| Equity | $5.90M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $5.90M |
| Liabilities And Equity | $44.18M |
| Net Cash Flow From Operating Activities | -$12.38M |
| Net Cash Flow From Operating Activities, Continuing | -$12.38M |
| Net Cash Flow From Investing Activities | -$415.00K |
| Net Cash Flow From Investing Activities, Continuing | -$415.00K |
| Net Cash Flow From Financing Activities | $9.31M |
| Net Cash Flow From Financing Activities, Continuing | $9.31M |
| Net Cash Flow | -$3.48M |
| Net Cash Flow, Continuing | -$3.48M |
| Comprehensive Income/Loss | -$15.43M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$15.43M |
| Other Comprehensive Income/Loss | -$7.23M |